|1.92||+0.09 / +4.92%|
Data as of 3:59pm ET
|1.83||-0.0881 / -4.59%|
The 7 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 2.25. The median estimate represents a +212.50% increase from the last price of 1.92.
The current consensus among 8 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.